Top Markets
#1 Helium Helium +49.84%
#2 TENDIES TENDIES +37.70%
#3 Pons Pons +29.59%
#4 Seeker Seeker +20.73%
#5 UnifAI Network UnifAI Network +15.18%
#6 pipedog pipedog +13.53%
#7 Songbird Songbird +12.18%
#8 StonkBroker StonkBroker +11.81%
#9 OSK OSK +9.95%
#10 Lista DAO Lista DAO +9.95%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
Climb Bio, Inc. Climb Bio, Inc.

Climb Bio, Inc.

CLYM
Rank in Stocks #10440
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic... Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Share Price
$14.66
Last synced: 2026-08-28
Market Cap
$839.37M
Change (1 day)
-2.67%
Change (1 year)
557.32%
Country
US
Trade Climb Bio, Inc. (CLYM)

Category

Healthcare
Stock price history for Climb Bio, Inc. (CLYM)
Highest end of day price: $15.73 on 2026-08-01

Lowest end of day price: $7.23 on 2024-09-01
Stock price history of Climb Bio, Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 113.43%
2025 31.56%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH